Product Comparison

Comparison Options

• Print
• Email

	No Image
McKesson #	1103786	981867	911398	952614
Description	INDICATOR, CO2 STAT-CHECK TRI-COLOR (10/CS)	TDVAX™ Tetanus and Diphtheria Toxoids Adsorbed 2 Lf - 2 Lf / 0.5 mL Injection 0.5 mL	Pneumovax® 23 Pneumococcal 23 Vaccine Polyvalent 25 mcg / 0.5 mL Injection 0.5 mL	Gardasil® 9 Human Papillomavirus 9-Valent Vaccine, Recombinant, Preservative Free 20 mcg - 60 mcg / 0.5 mL Injection 0.5 mL
Manufacturer #	SC200	13533013101	00006483703	00006412102
Brand		TDVAX™	Pneumovax® 23	Gardasil® 9
Manufacturer	SUN MED GROUP HO	Grifols Therapeutics Inc (TDVAX)	Merck	Merck
Invoice	INDICATOR, CO2 STAT-CHECK TRI-COLOR (10/CS)	TDVAX, SDV 0.5ML (10/PK)	PNEUMOVAX, SYR 0.5ML (10/CT)	GARDASIL 9 HPV VACC, SYR 0.5ML(10/BX)
	Log In to Order	Log In to Order	Log In to Order	Log In to Order
Comparison
Application		Td Vaccine	Pneumonia Vaccine	Human Papillomavirus Vaccine (HPV)
Container Type		Single-Dose Vial	Prefilled Syringe	Prefilled Syringe
Country of Origin	Unknown	Unknown	United States	United States
Dosage Form		Injection	Injection	Injection
Generic Drug Code		20835	43859	37568
Generic Drug Name		Tetanus and Diphtheria Toxoids Adsorbed	Pneumococcal 23 Vaccine Polyvalent	Human Papillomavirus 9-Valent Vaccine, Recombinant, Preservative Free
NDC Number		13533013101	00006483703	00006412102
Product Dating		McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 180 days
Storage Requirements		Requires Refrigeration	Requires Refrigeration	Requires Refrigeration
Strength		2 Lf - 2 Lf / 0.5 mL	25 mcg / 0.5 mL	20 mcg - 60 mcg / 0.5 mL
Type		Intramuscular	Intramuscular or Subcutaneous	Intramuscular
UNSPSC Code		51201629	51201615	51201649
User		Indicated for People 7 Years of Age and Older	Indicated for People 50 Years of Age and Older	Indicated for People 9 to 45 Years of Age
Volume		0.5 mL	0.5 mL	0.5 mL
Features and Benefits			PNEUMOVAX 23 is a vaccine indicated for active immunization for the prevention of pneumococcal disease caused by the 23 serotypes contained in the vaccine PNEUMOVAX 23 is approved for use in persons 50 years of age or older and persons aged >2 years who are at increased risk for pneumococcal disease Box of 10 single-dose, pre-filled Luer-Lok™ syringes with tip caps, color coded with a violet plunger rod and purple stripe on the syringe labels and cartons Store unopened and opened vials at 2° - 8°C (36° - 46°F)	GARDASIL 9 is a non-infectious recombinant 9-valent vaccine prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58 Each 0.5-mL dose contains approximately 30 mcg of HPV Type 6 L1 protein, 40 mcg of HPV Type 11 L1 protein, 60 mcg of HPV Type 16 L1 protein, 40 mcg of HPV Type 18 L1 protein, 20 mcg of HPV Type 31 L1 protein, 20 mcg of HPV Type 33 L1 protein, 20 mcg of HPV Type 45 L1 protein, 20 mcg of HPV Type 52 L1 protein, and 20 mcg of HPV Type 58 L1 protein Administer GARDASIL 9 intramuscularly as a 0.5-mL dose at the following schedule: 0, 2 months, 6 months Not all vulvar, vaginal, and anal cancers are caused by HPV, and GARDASIL 9 protects only against those vulvar, vaginal, and anal cancers caused by HPV 16, 18, 31, 33, 45, 52 and 58